Diabetes research and clinical practice · 2025
Diabetic retinopathy and chronic kidney disease synergistically increase the risk of incident cardiovascular disease in type 2 diabetes: Insights from two cohort studies.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Park Yeon Soo, Lee Kyu Na, Koo Bo Kyung, Kwak Soo Heon, Han Kyung Do, Moon Min Kyong
Аннотация
AIMS: Chronic kidney disease (CKD) is a well-established cardiovascular risk factor for type 2 diabetes (T2D); however, the role of diabetic retinopathy (DR) remains unclear. This study evaluated the individual and combined effects of DR and CKD on cardiovascular disease (CVD) in T2D.
METHODS: We analyzed individuals with T2D and no prior CVD from the Korean NHIS cohort (n = 2,064,406) and the UK Biobank (n = 21,350). The primary outcome was a composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke.
RESULTS: In the Korean cohort, adjusted hazard ratios (aHRs) for the primary outcome were elevated in those with PDR (aHR 1.37), CKD (aHR 1.36), and even more so when both were present (aHR 2.21), compared to individuals without DR or CKD. Similar results were observed in the UK Biobank. The effect of PDR on CVD was strongest in younger individuals, with aHRs of 3.28 (<40 years), 1.77 (40-64 years), and 1.29 (≥65 years) (Reference: No DR in each age group).
CONCLUSIONS: PDR and CKD, both independently and in combination, increase cardiovascular risk in individuals with T2D, particularly among younger age groups. These findings support incorporating PDR into cardiovascular risk assessment and management.
METHODS: We analyzed individuals with T2D and no prior CVD from the Korean NHIS cohort (n = 2,064,406) and the UK Biobank (n = 21,350). The primary outcome was a composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke.
RESULTS: In the Korean cohort, adjusted hazard ratios (aHRs) for the primary outcome were elevated in those with PDR (aHR 1.37), CKD (aHR 1.36), and even more so when both were present (aHR 2.21), compared to individuals without DR or CKD. Similar results were observed in the UK Biobank. The effect of PDR on CVD was strongest in younger individuals, with aHRs of 3.28 (<40 years), 1.77 (40-64 years), and 1.29 (≥65 years) (Reference: No DR in each age group).
CONCLUSIONS: PDR and CKD, both independently and in combination, increase cardiovascular risk in individuals with T2D, particularly among younger age groups. These findings support incorporating PDR into cardiovascular risk assessment and management.